Drug Pricing

Prescription drug prices continue to rise, threatening to make vital therapies unaffordable for many patients. Kaiser Permanente believes it is time for a new legal and policy landscape for drug pricing that rewards innovation and discovery, but also provides medicines at prices patients and the health care system can afford.

Featured Drug Pricing Content

Drug policy 101: Kaiser Permanente’s Approach to Pharmaceutical Detailing
How pharmaceutical marketing affects decisions about patient care
Building a bigger table for a more equitable drug development system
Biosimilars at Kaiser Permanente
Load More

Drug Policy 101 Series

Health care workforce needs and Kaiser Permanente’s approach
Drug policy 101: Kaiser Permanente’s Approach to Pharmaceutical Detailing
How pharmaceutical marketing affects decisions about patient care
Drug policy 101: Pharmaceutical marketing tactics
Load More

Prescription Drug Forums

This forum brought together leaders from across sectors together in Washington, D.C. to discuss the drug pricing landscape and elevate effective policy solutions.

View Building Racial Equity into the Drug Development System (Part 2) View Building Racial Equity into the Drug Development System (Part 1) View Unpacking Drug Value View Addressing High Drug Pricing forum

Fast Facts

1 in 4

1 in 4 people in the U.S. have difficulty affording their medication 1

cost of medication

3 in 10 adults  reported skipping their medications because of cost in the past year 2

Half of drug costs

Specialty drugs are projected to make up 50% of all U.S. pharmacy costs even though they account for a small percentage of prescriptions 3